DiaSys Corporation Announces First Quarter Financial Information

DiaSys Corporation (AMEX:DYX) a global healthcare
products company, has announced a net loss of $240,507 $(.01) per
share on net sales of $447,143 for its first quarter ended September
30, 2005. For the first quarter ending September 30, 2004, the company
had a net loss of $491,999 $(.03) per share on net sales of $564,812.
   DiaSys Corporation designs, develops, manufactures and distributes
proprietary medical laboratory equipment, consumables and infectious
disease test-kits to healthcare & veterinary laboratories worldwide.
Headquartered in Waterbury, Connecticut USA, the Company operates in
Europe through its wholly owned subsidiary based in Wokingham, England
and in Pacific Asia through its strategic business partner located in
Guangzhou, China. DiaSys, Parasep and Urisep are registered trademarks
of DiaSys Corporation.

   This press release contains forward-looking statements within the
meaning of, and made pursuant to, the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. The forward looking
statements involve known and unknown risks, uncertainties and other
factors which may cause the actual results, performance or
achievements of the Company or events, or timing of events, relating
to the Company to materially differ from those expressed or implied by
such forward looking statements. DiaSys refers interested parties to
its most recent Annual Report on Form 10-KSB and other SEC filings for
a complete description of, and discussions about, the Company.